Literature DB >> 4162242

Experimental and clinical studies of radiosensitizers in brain tumors, with special reference to BUdR-antimetabolite continuous regional infusion-radiation therapy (BAR therapy).

K Sano, F Sato, T Hoshino, M Nagai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 4162242     DOI： 10.2176/nmc.7.51

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN： 0470-8105            Impact factor:   1.742


× No keyword cloud information.
  4 in total

1.  [Results of postoperative treatment of glioblastoma multiforme with a radiation-sensitizing substance (5-bromo-2-deoxyuridine)].

Authors:  A M Landolt
Journal:  Acta Neurochir (Wien)       Date:  1971       Impact factor: 2.216

Review 2.  [Cellular replacement strategies and adult neurogenesis in idiopathic Parkinson's disease].

Authors:  F Marxreiter; A Storch; J Winkler
Journal:  Nervenarzt       Date:  2016-08       Impact factor: 1.214

3.  Experimental studies on potentiation of the antitumor activity of 5-fluorouracil with 3'-azido-3'-deoxythymidine for the gastric cancer cell line MKN28 in vivo.

Authors:  C Yasuda; M Kato; D Kuroda; H Ohyanagi
Journal:  Jpn J Cancer Res       Date:  1997-01

4.  Proliferative activity of human tumors: assessment using bromodeoxyuridine and flow cytometry.

Authors:  T Shimomatsuya; N Tanigawa; R Muraoka
Journal:  Jpn J Cancer Res       Date:  1991-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.